These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8112636)
1. Risk factors for cervical cancer by histology. Brinton LA; Herrero R; Reeves WC; de Britton RC; Gaitan E; Tenorio F Gynecol Oncol; 1993 Dec; 51(3):301-6. PubMed ID: 8112636 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of cervical cancer by cell type. Brinton LA; Tashima KT; Lehman HF; Levine RS; Mallin K; Savitz DA; Stolley PD; Fraumeni JF Cancer Res; 1987 Mar; 47(6):1706-11. PubMed ID: 3815368 [TBL] [Abstract][Full Text] [Related]
3. Determinants of the geographic variation of invasive cervical cancer in Costa Rica. Herrero R; Brinton LA; Hartge P; Reeves WC; Breñes MM; Urcuyo R; Pacheco M; Fuster F; Sierra R Bull Pan Am Health Organ; 1993; 27(1):15-25. PubMed ID: 8490673 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for cervical neoplasia in Denmark. Kjaer SK APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for invasive carcinoma of the uterine cervix in Latin America. Herrero R; Brinton LA; Reeves WC; Brenes MM; Tenorio F; de Britton RC; Gaitán E; Montalván P; García M; Rawls WE Bull Pan Am Health Organ; 1990; 24(3):263-83. PubMed ID: 2171706 [TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. Peters RK; Thomas D; Hagan DG; Mack TM; Henderson BE J Natl Cancer Inst; 1986 Nov; 77(5):1063-77. PubMed ID: 3464798 [TBL] [Abstract][Full Text] [Related]
8. On the etiology of anal squamous carcinoma. Frisch M Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281 [TBL] [Abstract][Full Text] [Related]
9. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474 [TBL] [Abstract][Full Text] [Related]
10. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Rosenquist K Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030 [TBL] [Abstract][Full Text] [Related]
11. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972 [TBL] [Abstract][Full Text] [Related]
12. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results. Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117 [TBL] [Abstract][Full Text] [Related]
13. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX; J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827 [TBL] [Abstract][Full Text] [Related]
14. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Hsieh CY; You SL; Kao CL; Chen CJ Anticancer Res; 1999; 19(5C):4495-500. PubMed ID: 10650799 [TBL] [Abstract][Full Text] [Related]
15. Risk of invasive cervical cancer after three consecutive negative Pap smears. Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with tumour stage at presentation in invasive cervical cancer. Ndlovu N; Kambarami R Cent Afr J Med; 2003; 49(9-10):107-11. PubMed ID: 15298465 [TBL] [Abstract][Full Text] [Related]
17. Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Pukkala E; Malila N; Hakama M Acta Oncol; 2010; 49(2):180-4. PubMed ID: 20001504 [TBL] [Abstract][Full Text] [Related]
18. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828 [TBL] [Abstract][Full Text] [Related]
19. [Possible link between long-term oral contraceptive use and cervical cancer]. Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054 [TBL] [Abstract][Full Text] [Related]
20. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]